Uni-Bio Science Group Announces 2025 Interim Results
- Written by Media Outreach
EPS Surged to 1.27 HK Cents with a Three-year CAGR of 43.1%, Robust Revenue Growth Driven by Strong Demand for Bogutai® and Omnichannel Strategy
HONG KONG SAR - EQS Newswire - 28 August 2025 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the...Read more: Uni-Bio Science Group Announces 2025 Interim Results